FDA has cleared Novo Nordisk’s NovoPen Echo insulin injection device, which is the only one available in the U.S. that is capable of delivering half-unit doses of insulin.
FDA has cleared Novo Nordisk’s NovoPen Echo insulin injection device, which is the only one available in the U.S. that is capable of delivering half-unit doses of insulin. This is a boon for diabetic children who need insulin in reduced doses. It also comes with a digital readout that gives the time of the previous injection. This information is valuable to parents as they can ascertain if children are administering insulin as per the need.
Diabetes is a group of diseases with one thing in common - a problem with insulin. The problem could be that your body doesn't make any insulin, doesn't make enough insulin or doesn't use insulin properly.
Type 1 Diabetes - This type of diabetes is an autoimmune disease. Your immune system turns on itself and destroys the insulin-producing cells in your pancreas. Although Type 1 diabetes usually develops in childhood or teen years, it can appear later.
Type 2 Diabetes -In this type, your pancreas makes some insulin, but not enough. Your cells also can become resistant to insulin's effects, keeping insulin from escorting enough glucose into your body's cells. Type 2 diabetes generally develops after age 40. However, doctors are seeing a rise in childhood Type 2 diabetes that parallels the rise in obesity among youth.
Source-Medindia